CARISMA Therapeutics Inc
(OTCPK:CARM)
$
0.0025
(0%)
Market Cap: 105,000.00
Enterprise Value: -1.91 Mil
PE Ratio: 0.01
PB Ratio: 0
GF Score: 0/100 Carisma Therapeutics Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) Transcript
Apr 24, 2023 / 03:00PM GMT
Release Date Price:
$4.15
(+1.47%)
Daniil Gataulin
Chardan Capital Markets LLC - Analyst
Good morning and thank you for attending Chardan's 7th Annual Genetic Medicines Cell Manufacturing Summit. My name is Daniil Gataulin. I'm one of the senior research analysts covering biotech here Chardan.
It is my pleasure to introduce our next guests from Carisma Therapeutics, Steven Kelly, President and CEO; and Michael Klichinsky, Co-Founder and CSO. Steven, Michael, Welcome.
Steven Kelly
Carisma Therapeutics Inc. - President & CEO
Thank you very much. Pleasure to be here.
Michael Klichinsky
Carisma Therapeutics Inc. - Co-Founder & Chief Scientific Officer
Thank you for having me.
Daniil Gataulin;Steven Kelly
Chardan Capital Markets LLC - Analyst;Carisma Therapeutics Inc. - President
(Conference Instructions) With that, I think we should go ahead and start. Steve, if you could spend a few minutes and please give us a brief overview of Charisma to get us going.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot